KBR has filed a Form 10 registration statement with the U.S. SEC as it prepares to spin off its Mission Technology Solutions business into a standalone company, Trinzic, to be listed on the NYSE under the ticker TZIC. Trinzic is expected to launch with more than $5 billion in annual revenue, 18,000 employees and a global operating footprint. KBR said it plans to provide supplemental financial information alongside its third-quarter earnings release to help investors assess the standalone profiles of Trinzic and the remaining KBR business.

Micron Technology reported record results for fiscal fourth-quarter and full-year 2026. DRAM quarterly revenue jumped 343% year over year to $39.8 billion, while data center revenue surged to $18.0 billion from $1.57 billion a year earlier. NAND quarterly revenue also climbed 526% to $14.1 billion, with all three figures marking record highs.

During its fiscal 2026 fourth-quarter earnings call, FactSet said it expects fiscal 2027 organic annual subscription value (ASV) growth of 5% to 6.5% and margin improvement of 25 to 75 basis points. The company also highlighted record ASV, momentum in artificial intelligence and its MCP business, and the BCC acquisition. It characterized the outlook as a routine annual guide rather than an unexpected market catalyst.

Micron Technology reported record fiscal fourth-quarter results, with revenue and margins coming in well above market expectations. The gains were driven mainly by AI-led demand for HBM (high-bandwidth memory) and data centers. The company also issued forward guidance that materially exceeded consensus and said it has secured HBM contracts through 2027, with growth expected to continue into 2028.

A federal judge approved a settlement that clears the final regulatory hurdle for Paramount’s $111 billion acquisition of Warner Bros. Discovery, with the deal expected to close on Oct. 6. The settlement requires the combined company to release at least 30 theatrical films a year for the first two years, rising to 32 for the next three, while meeting minimum levels for wide and independent releases and ensuring more than half are produced or co-produced in-house. Missing the quota triggers a $30 million per-film penalty, and continued shortfalls could force Paramount to divest its stake in Miramax. The transaction had faced an antitrust challenge alleging reduced competition across streaming, news and theatrical distribution.

A US federal court in Delaware ruled that Liquidia’s lung drug Yutrepia infringed two foundational claims of United Therapeutics’ '327 patent, sending Liquidia shares down nearly 50% on Wednesday. United Therapeutics shares rose 12.3% the same day. Liquidia said it disagrees with the decision, will pursue appellate options and plans to ask the FDA to remove the PH-ILD indication from Yutrepia’s label. A final judgment is expected within about a week.

Progress Software reported fiscal third-quarter net income of $22.8 million, or 55 cents per share, with adjusted earnings of $1.69 per share. Revenue for the quarter was $246 million. For the quarter ending in November, the company forecast per-share earnings of $1.24 to $1.33 and revenue of $297 million to $305 million. For the full year, it projected earnings of $6.15 to $6.23 per share on revenue of $1.04 billion to $1.05 billion.

Bassett Furniture Industries reported fiscal third-quarter results, with net income of $0.24 a share on a diluted basis, up from $0.09 a year earlier. The figure also topped the $0.13 consensus estimate from two analysts surveyed by FactSet.